back to top
HomeTagsRetinal

retinal

Merck acquires EyeBio to spice up retinal illness remedy By Investing.com

RAHWAY, N.J. - Merck & Co., Inc. (NYSE: MRK) has accomplished the acquisition of Eyebiotech Restricted (EyeBio), now a completely built-in subsidiary, enhancing its...

Most Popular

spot_img